Fatty Acids and the Aging Brain

Omega-3 Fatty Acids in Brain and Neurological Health

Volumn , Issue , 2014, Pages 201-219

  Bianca Velasco, Alyssa ^a   Tan, Zaldy S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; Alzheimer s disease; dementia; DHA; docosahexaenoic acid; eicosapentaenoic acid; EPA; Omega 3 polyunsaturated fatty acids; PUFA

Indexed keywords

EID: 85081378242     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-410527-0.00017-X     Document Type: Chapter

References (231)

1. A. Acheson, J. Conover, J. Fandl, T. Dechiara, M. Russell, A. Thadani, et al. (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374(6521), 450-453.
2. A. Ahmad, T. Moriguch and N. Salem Jr (2002) Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr. Neurol. 26 210-218.
3. S. Aid, S. Vancassel, C. Poumes-Ballihaut, S. Chalon, P. Guesnet and M. Lavialle (2003) Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J. Lipid. Res. 44 1545-1551.
4. J. Allen (2005) Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region. Neurobiol. Aging 26(9), 1245-1260. discussion p.1279–1282
5. P. Alverzo (2006) A review of the literature on orientation as an indicator of level of consciousness. J. Nurs. Scholarsh. 38(2), 159-164.
6. Alzheimer’s Association (2010) Alzheimer’s disease facts and figures. Alzheimers Dement. 6 158-194.
7. L. Arab (2003) Biomarkers of fat and fatty acid intake. J. Nutr. 133(Suppl. 3), 925S-932S.
8. R. Au and S. Seshadri (2004) New norms for a new generation: cognitive performance in the Framingham Offspring Cohort. Exp. Aging Res. 30 333-358.
9. L. Bäckman (2010) Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues. Neurosci. Biobehav. Rev. 34(5), 670-677.
10. L. Bäckman, S. Jones, A. Berger, A. Laukka and B. Small (2004) Multiple cognitive deficits during the transition to Alzheimer’s disease. J. Intern. Med. 256(3), 195-204.
11. A. Baddeley (2002) Fractionating the central executive. D. Stuss, R. Knight (Eds) Principles of Frontal Lobe Function first ed. Oxford: Oxford University Press 246.
12. P. Baltes and U. Lindenberger (1997) Emergence of a powerful connection between sensory and cognitive functions across the adult lifespan: a new window to the study of cognitive aging? Psychol. Aging 12 12.
13. P. Barberger-Gateau, L. Letenneur, V. Deschamps, K. Peres, J. Dartigues and S. Renaud (2002) Fish, meat, and risk of dementia: cohort study. BMJ 325(7370), 932-933.
14. C. Barnes and S. Burke (2006) Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7(1), 30-40.
15. G. Bartzokis, M. Beckson, P. Lu, K. Nuechterlein, N. Edwards and J. Mintz (2001) Age-related changes in frontal and temporal volume in men: a magnetic resonance imaging study. Arch. Gen. Psychiat. 58 461-465.
16. A. Benraiss, E. Chmielnicki, K. Lerner, D. Roh and S. Goldman (2001) Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J. Neurosci. 21(17), 6718-6731.
17. A. Benton, P. Eslinger and A. Damasio (1981) Normative observations on neuropsychological test performances in old age. J. Clin. Neuropsychol. 3 33-42.
18. J. Birren and D. Morrison (1961) Analysis of the WAIS subtests in relation to age and education. J. Gerontol. 16 363-369.
19. K. Bonaa, K. Bjerve, B. Straume, I. Gram and D. Thelle (1990) Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: a population-based intervention trial from the Tromsø study. N. Engl. J. Med. 322 795-801.
20. S. Boncristiano, M. Calhoun and P. Keely (2002) Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J. Neurosci. 22 3234-3243.
21. C. Bouras, P. Hof, P. Giannakopoulos, J. Michel and J. Morrison (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex 4(2), 138-150.
22. J. Bowler and V. Hachinski (Eds) (2003) Vascular Cognitive Impairment Oxford and New York: Oxford University Press
23. J. Brenna (2002) Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care. 5 127-132.
24. British Nutrition Foundation (1992) Unsaturated Fatty Acids: Nutritional and Physiological Significance London: Chapman and Hall
25. A. Burns, R. Jacoby and R. Levy (1991) Neurological signs in Alzheimer’s disease. Age. Ageing 1 45-51.
26. K. Cagney and D. Lauderdale (2002) Education, wealth, and cognitive function in later life. J. Gerontol. B Psychol. Sci. Soc. Sci. 57 163-172.
27. P. Calder (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. 107 1-11.
28. F. Calon, G. Lim and F. Yang (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron 43(5), 633-645.
29. J. Carrier, A. Cheyne, G. Solman and D. Smilek (2010) Age trends for failures of sustained attention. Psychol. Aging 25(3), 569-574.
30. S. Chalon, S. Delion-Vancassel and C. Belzung (1998) Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr. 128 2512-2519.
31. S. Chen and D. Hillman (1999) Dying-back of Purkinje cell dendrites with synapse loss in aging rats. J. Neurocytol. 28(3), 187-196.
32. H. Christensen, A. Korten, A. Jorm, A. Henderson, P. Jacomb, B. Rodgers, et al. (1997) Education and decline in cognitive performance: compensatory but not protective. Int. J. Geriatr. Psychiatry 12 323-330.
33. W. Chun and G. Johnson (2007) The role of tau phosphorylation and cleavage in neuronal cell death. Front. Biosci. 12 733-756.
34. G. Cole and S. Frautschy (2010) DHA may prevent age-related dementia. J. Nutr. 140 869-874.
35. G. Cole and Q. Ma (2009) Omega-3 fatty acids and dementia. Prostaglandins Leukot. Essent. Fatty Acids 81 213-221.
36. W. Connor, M. Neuringer and D. Lin (1990) Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J. Lipid. Res. 31 237-247.
37. J. Conquer, M. Tierney, J. Zecevic, W. Bettger and R. Fisher (2000) Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids 35 1305-1312.
38. M. Corrada and R. Brookmeyer (2008) Prevalence of dementia after age 90: results from the 90+ study. Neurology 71 337.
39. P. Coti Bertrand, J. O’Kusky and S. Innis (2006) Maternal dietary n-3 fatty acid deficiency alters neurogenesis in the embryonic rat brain. J. Nutr. 36 1570-1575.
40. J. Court, E. Perry and K. Kalaria (2002) Neurotransmitter control of the cerebral vasculature and abnormalities in vascular dementia. T. Erkinjuntti, S. Gauthier (Eds) Vascular Cognitive Impairment first ed. London: Dunitz 167-185.
41. F. Craik (1986) A functional account of age differences in memory. F. Klix, H. Hagendorf (Eds) Human Memory and Cognitive Capabilities, Mechanisms and Performances first ed. Amsterdam: Elsevier 409.
42. F. Craik and T. Salthouse (Eds) (2000) The Handbook of Aging and Cognition Mahwah, N.J: Lawrence Erlbaum Associates
43. F. Craik and M. Byrd (1982) Aging and cognitive deficits: the role of attentional resources. F. Craik, S. Trehub (Eds) Aging and Cognitive Processes first ed. New York: Plenum 191.
44. M. Crawford and A. Sinclair (1972) Nutritional influences in evolution and mammalian brain. Ciba Foundation Symposium (Eds) Lipids, Malnutrition and the Developing Brain first ed. Amsterdam: Associated Scientific Publishers 267-287.
45. M. Crawford, N. Casperd and A. Sinclair (1976) The long-chain metabolites of linoleic and linolenic acids in liver and brain in herbivores and carnivores. Comp. Biochem. Physiol. 54(B), 395-401.
46. J.L. Cummings and G. Cole (2002) Alzheimer disease. JAMA 287 2335-2338.
47. P. Davidson and E. Glisky (2002) Neuropsychological correlates of recollection and familiarity in normal aging. Cogn. Affect. Behav. Neurosci. 2 174.
48. S. de la Presa Owens and S. Innis (2000) Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 48 125-130.
49. C. Decarli and J. Masaro (2005) Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol. Aging 26 491-510.
50. R. Decaterina and G. Basta (2001) n-3 fatty acids and the inflammatory response – biological background. Eur. Hear. J. Suppl. 3(Suppl. D), D42-D49.
51. S. Delion, S. Chalon, D. Guilloteau, J. Besnard and G. Durand (1996) Alpha-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 66 1582-1591.
52. D. Demke, G. Peters, O. Linet, C. Metzler and K. Klott (1998) Effects of a fish oil concentrate in patients with hypercholesterolemia. Atherosclerosis 70 73-80.
53. G. Der and I. Deary (2006) Reaction time age changes and sex differences in adulthood. Results from a large, population based study: the UK Health and Lifestyle Survey. Psychol. Aging 21 62-73.
54. D. Drachman, R. Friedland, E. Larson and M. Williams (1991) Making sure it’s really Alzheimer’s. Patient Care 11 13-41.
55. H. Duan and S. Wearne (2003) Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb. Cortex 13(9), 950-961.
56. J. Dyerberg, H. Bang, E. Stoffersen, S. Moncada and J. Vane (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2 117-119.
57. R. Engle (2002) Working memory capacity as executive attention. Curr. Dir. Psychol. Sci 11 19-23.
58. E. Englund (2000) Neuropathology of white matter disease: parenchymal changes. L. Pantoni, A. Wallin (Eds) The Matter of White Matter. Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia first ed. Utrecht: Academic Pharmaceutical Productions 223-246.
59. D. Evans (1996) The epidemiology of dementia and Alzheimer’s disease: an evolving field. J. Am. Geriatr. Soc. 44 1482. 44 (1482), (accessed 05.03.13)
60. S. Fischer and P. Weber (1983) Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5w3). Biochem. Biophys. Res. Commun. 116 1091-1099.
61. C. Fisher (1982) Lacunar strokes and infarcts: a review. Neurology 32 871-876.
62. A. Fjell (2010) Structural brain changes in aging: courses, causes and cognitive consequences. Rev. Neurosci. 21(3), 182-221.
63. A. Fjell, K. Walhovd, I. Reinvang, A. Lundervold, A. Dale, B. Quinn, et al. (2005) Age does not increase rate of forgetting over weeks—neuroanatomical volumes and visual memory across the adult life-span. J. Int. Neuropsychol. Soc. 11 2-15.
64. S. Florent-Béchard and C. Malapate-Armand (2007) Towards a nutritional approach for prevention of Alzheimer’s disease: biochemical and cellular aspects. J. Neurol. Sci. 262 27-36.
65. S. Florent-Béchard, V. Koziel, J. Olivier, T. Oster and T. Pillot (2007) Neuroprotective effects of DHA in Alzheimer’s disease models. Oléagineux, Corps gras et Lipides (OCL) 14 186-189.
66. M. Fokkema, D. Brouwer, M. Hasperhover, Y. Hettema, W. Bemelmans and F. Muskiet (2000) Polyunsaturated fatty acid status of Dutch vegans and omnivores. Prostaglandins Leukot. Essent. Fatty Acids 63 279-285.
67. H. Förstl and A. Kurz (1999) Clinical features of Alzheimer’s disease. Eur. Arch. Psychiatry. Clin. Neurosci. 249(6), 288-290.
68. A. Fotenos (2005) Normative estimates of cross-sectional and longitudinal brain volume decreases in aging and AD. Neurology 64(6), 1032-1039.
69. M. Fotuhi, P. Mohassel and K. Yaffe (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat. Clin. Pract. Neurol. 5(3), 140-152.
70. Y. Freund-Levi, M. Eriksdotter-Jonhagen and T. Cederholm (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63 1402-1408.
71. C. Funk (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294(5548), 1871-1875.
72. J. Giedd, J. Blumenthal, N. Jeffries, F. Castellanos, H. Liu, A. Zijdenbos, et al. (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 2 861-863.
73. E. Glisky (2007) Changes in cognitive function in human aging. D. Riddle (Eds) Brain Aging: Models, Methods, and Mechanisms first ed. Boca Raton, FL: CRC Press
74. M. Goedert, M. Spillantini and R. Crowther (1991) Tau proteins and neurofibrillary degeneration. Brain. Pathol. 1(4), 279-286.
75. S. Goodknight, W. Harris and W. Connor (1981) The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective controlled study. Blood 58 880-885.
76. K. Green, H. Martinez-Coria and H. Khashwji (2007) Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 25(12), 3032-3040.
77. P. Green, S. Glozman, L. Weiner and E. Yavin (2001) Enhanced free radical scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl docosahexaenoate. Biochim. Biophys. Acta. 26 210-218.
78. V. Hachinski and J. Bowler (1993) Vascular dementia. Neurology 43 2159-2160.
79. W. Harris (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharcacol. Res. 55 217-223.
80. W. Harris and D. Bulchandani (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr. Opin. Lipidol. 17(4), 387-393.
81. W. Harris and C. von Schacky (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev. Med. 39 212-220.
82. S. Hart, C. Smith and M. Swash (1988) Word fluency in patients with early dementia of Alzheimer type. Br. J. Clin. Psychol. 27(2), 115-124.
83. L. Hasher, R. Zacks and C. May (1999) Inhibitory control, circadian arousal, and age. D. Gopher, A. Koriat (Eds) Attention and Performance XVII first ed. Cambridge: MIT Press 653.
84. T. Hedden and J. Gabrieli (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 5 87-96.
85. E. Helzner, J. Luchsinger, N. Scarmeas, S. Consentino, A. Brickman, M. Glymour, et al. (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol. 2009(66), 343-348.
86. F. Hernández and J. Avila (2007) Tauopathies. Cell. Mol. Life Sci. 64(17), 2219-2233.
87. B. Heude, P. Ducimetiere and C. Berr (2003) Cognitive decline and fatty acid composition of erythrocyte membranes: the EVA Study. Am. J. Clin. Nutr. 77 803-808.
88. J. Hibbeln, L. Nieminen, T. Blasbalg, J. Riggs and W. Lands (2006) Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am. J. Clin. Nutr. 83(6 Suppl), 1483S-1493S.
89. A. Hjartaker, E. Lund and K. Bjerve (1997) Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur. J. Clin. Nutr. 51 736-742.
90. E. Hoekzema (2010) The effects of aging on dopaminergic neurotransmission: a microPET study of [11C]-raclopride binding in the aged rodent brain. Neuroscience 171(4), 1283-1286.
91. G. Hopp, R. Dixon, M. Grut and L. Bacekman (1997) Longitudinal and psychometric profiles of two cognitive status tests in very old adults. J. Clin. Psychol. 53 673-686.
92. M. Hossain, M. Hashimoto and S. Masumura (1998) Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. Neurosci. Lett. 244 157-160.
93. E. Huang and L. Reichardt (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24 677-736.
94. A. Ikemoto, A. Nitta and S. Furukawa (2000) Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci. Lett. 285 99-102.
95. S. Innis (2003) Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J. Pediatr. 143 S1-S8.
96. S. Innis (2007) Dietary (n-3) fatty acids and brain development. J. Nutr. 137 855-859.
97. K. Iqbal (2005) Pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta. 1739(2–3), 198-210.
98. M. Iyo and T. Yamasaki (1993) The detection of age-related decrease of dopamine, D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17(3), 415-421.
99. L. Jarskog (1997) Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int. J. Dev. Neurosci. 15(6), 711-716.
100. J. Jennings and L. Jacoby (1997) An opposition procedure for detecting age-related deficits in recollection: telling effects of repetition. Psychol. Aging 12 352.
101. T. Jernigan, S. Archibald, C. Fenema-Notestine, A. Gamst, J. Stout, J. Bonner, et al. (2001) Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol. Aging 22 581-594.
102. E. Johnson, K. McDonald, S. Caldarella, H. Chung, A. Troen and D. Snodderly (2008) Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr. Neurosci. 11(2), 75-83.
103. V. Kaasinen, H. Vilkman, J. Hietala, K. Någren, H. Helenius, H. Olsson, et al. (2000) Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol. Aging 21(5), 683-688.
104. S. Kalmijn and L. Launer (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42 776-782.
105. J. Kapfhammer and M. Schwab (1994) Inverse patterns of myelination and GAP-43 expression in the adult CNS: neurite growth inhibitors as regulators of neuronal plasticity? J. Comp. Neurol. 340 194-206.
106. Y. Katayama, T. Katsumata, H. Muramatsu, K. Usuda, R. Obo and A. Terashi (1997) Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP). Brain. Res. 761 300-305.
107. R. Katzman (1989) The dementias: Alzheimer disease. L. Rowland (Eds) Merritt’s Textbook of Neurology eight ed. Philadelphia: Lea & Febiger 637-644.
108. E. Kawakita, M. Hashimotot and O. Shido (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139 991-997.
109. S. Keli, E. Feskens and D. Kromhout (1994) Fish consumption and risk of stroke: The Zutphen Study. Stroke 25 328-332.
110. D. Kelley, D. Siegel, M. Vemuri and B. Mackey (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am. J. Clin. Nutr. 86(2), 324-333.
111. E. Kensinger (2009) Cognition in aging and age related disease. P. Hof, C. Mobbs (Eds) Handbook of the Neuroscience of Aging first ed. London: Elsevier 249-256.
112. J. Kinsella, B. Lokesh and R. Stone (1990) Dietary n-3 polyunsaturated acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clin. Nutr. 52 1-28.
113. M. Kivipelto, E. Helkala and M. Laakso (2001) Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal population based study. BMJ 322 1447-1451.
114. W. Klein, G. Krafft and C. Finch (2001) Targeting small Abeta oligomers: the solution to an Alzheimer’s disease conundrum? Trends. Neurosci. 24 219-224.
115. H. Knapp and G. Fitzgerald (1989) The antihypertensive effects of fish oil: a controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med. 320 1037-1043.
116. A. Kok (2000) Age-related changes in involuntary and voluntary attention as reflected in components of the event-related potential (ERP). Biol. Psychol. 54(1–3), 107-143.
117. P. Kris-Etherton, W. Harris and L. Appel (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 2747-2757.
118. D. Kritchevsky (1990) Trans unsaturated fat in nutrition and health. E. Erickson (Eds) Edible Fats and Oils Processing: Basic Principles and Modern Practices first ed. Champaign: American Oil and Chemistry Society 158-165.
119. X. Kuang, J. Du, Y. Liu, G. Zhang and H. Peng (2008) Postischemic administration of Z-ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats. Pharmacol. Biochem. Behav. 88 213-221.
120. K. Kubo, M. Saito, T. Tadokoro and A. Maekawa (1998) Dietary docosahexaenoic acid dose does not promote lipid peroxidation in rat tissue to the extent expected from peroxidizability index of the lipids. Biosci. Biotechnol. Biochem. 62 1698-1706.
121. W. Lands (2005) Fish, Omega 3 and Human Health Champaign, Ill: AOCS Press
122. M. Lane and S. Bailey (2005) Role of retinoid signaling in the adult brain. Prog. Neurobiol. 75 275-293.
123. D. Laurin and R. Verreault (2003) Omega-3 fatty acids and risk of cognitive impairment and dementia. J. Alzheimer’s Dis. 5 315-322.
124. A. Lee (2011) Vascular dementia. Chonnam. Med. J. 47(2), 66-71.
125. J. Lengqvist, A. Mata De Urquiza, A. Bergman, T. Willson, J. Sjovall, T. Perlmann, et al. (2004) Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell. Proteomics. 3 692-703.
126. B. Levine (2002) Aging and autobiographical memory: dissociating episodic from semantic retrieval. Psychol. Aging 17 677.
127. L. Light (1991) Memory and aging: Four hypotheses in search of data. Annu. Rev. Psychol. 42 333-376.
128. G. Lim, F. Calon and T. Morihara (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25(2), 3032-3040.
129. W. Lim, J. Gammack, J. Van Niekerk and A. Dangour (2013) Omega 3 fatty acid for the prevention of dementia. Cochrane. Database. Syst. Rev. 1 CD005379.
130. Y. Liu (2005) Tumor necrosis factor-alpha and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture. Brain. Res. 1054(2), 152-158.
131. W. Longstreth, T. Manolio and A. Arnold (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The cardiovascular health study. Stroke 27 1274-1282.
132. R. Lorenz, U. Spengler, S. Fischer, J. Duhm and P. Weber (1983) Platelet function, thromboxane formation, and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 67 504-511.
133. V. Magnotta (1999) Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging. Cereb. Cortex. 9(2), 151-160.
134. J. Marcusson, L. Oreland and B. Winblad (1984) Effect of age on human brain serotonin (S-1) binding sites. J. Neurochem. 43(6), 1699-1705.
135. C. Marx (2001) Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol. Psychiatry 50(10), 743-749.
136. J. McDowd and R. Shaw (2000) Attention and aging: a functional perspective. F. Craik, T. Salthouse (Eds) The Handbook of Aging and Cognition first ed. Mahwah: Erlbaum 221.
137. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E. Stadlan (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34 939-944.
138. S. Mirra, A. Heyman and K. Mckeel (1991) The Consortium to Establish a Registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41 479-486.
139. M. Monje (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651), 1760-1765.
140. S. Mora, M. Szklor, J. Otvos, P. Greenland, B. Psaty, D. Goff, et al. (2007) LDL particle subclasses, LOL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192 211-217.
141. M. Morris and D. Evans (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60 940-946.
142. M. Mullan (2000) Genetic contributions to causes of Alzheimer’s disease: current perspectives and future directions. J. Clin. Psychiatry 61(4), 307-315. Pp. 307–309. In: New Insights into Genetics and Pathophysiology of Alzheimer’s Disease: What are the Clinical and Therapeutic Implications? [Academic Highlights]
143. B. Murdoch, H. Chenery, V. Wilks and R. Boyle (1987) Language disorders in dementia of the Alzheimer type. Brain. Lang. 31(1), 122-137.
144. F. Muskiet and M. Fokkema (2004) Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized control trials. J. Nutr. 134 183-186.
145. A. Nasjletti (1998) The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 31 194-200.
146. M. Nicholas, C. Barth, L. Obler, R. Au and M. Albert (1997) Naming in normal aging and dementia of the Alzheimer’s type. H. Goodglass, A. Wingfield (Eds) Anomia: Neuroanatomical and Cognitive Correlates first ed. San Diego: Academic Press 166-188.
147. S. Nolde, M. Johnson and M. D’esposito (1998) Left prefrontal activation during episodic remembering: an event-related fMRI study. NeuroReport 9 3509.
148. P. Norris, C. Jones and M. Weston (1986) Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Br. Med. J. 293 104-105.
149. J. O’Brien (1986) Stability of the myelin membrane. Science 147 1099-1107.
150. J. O’Brien, D. Fillerup and J. Mead (1964) Quantification and fatty acid and fatty aldehyde composition of ethanolamine, choline, and serine glycerophosphatides in human cerebral gray and white matter. J. Lipid. Res. 5 329-338.
151. S. Ohnishi and K. Takano (2004) Amyloid fibrils from the viewpoint of protein folding. Cell. Mol. Life Sci. 61(5), 511-524.
152. M. Okada, T. Amamoto and M. Tomonaga (1996) The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience 71 17-25.
153. M. Ota, F. Yasuno, H. Ito, C. Seki, S. Kozaki, T. Asada, et al. (2006) Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[β-11C]DOPA. Life Sci. 79(8), 730-736.
154. D. Park and P. Reuter-Lorenz (2009) The adaptive brain: aging and neurocognitive scaffolding. Annu. Rev. Psychol. 60 173-196.
155. C. Peltz, G. Gratton and M. Fabiani (2011) Age-related changes in electrophysiological and neuropsychological indices of working memory, attention control, and cognitive flexibility. Front Psychol. 2 190.
156. V. Pencea, K. Bingaman, S. Wiegand and M. Luskin (2001) Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J. Neurosci. 21(17), 6706-6717.
157. A. Philibert, C. Vanier, N. Abdelouahab, H. Chan and D. Mergler (2006) Fish intake and serum fatty acid profiles from freshwater fish. Am. J. Clin. Nutr. 84 1299-1307.
158. T. Pillot, B. Drouet and S. Queille (1999) The nonfibrillar amyloid β-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 73 1626-1634.
159. P. Piperhoff (2008) Deformation field morphometry reveals age-related structural differences between the brains of adults up to 51 years. J. Neurosci. 28(4), 828-842.
160. J. Quinn, R. Raman and R. Thomas (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304 1903-1911.
161. P. Rabbitt (2001) Frontal tests and models for cognitive ageing. Eur. J. Cog. Psy. 13(1–2), 5-28.
162. N. Raz (2000) Aging of the brain and its impact on cognitive performance: integration of structural and functional findings. F. Craik, T. Salthouse (Eds) The Handbook of Aging and Cognition second ed. Mahwah: Erlbaum 1.
163. N. Raz and U. Lindenberger (2005) Regional brain changes in aging healthy adults: general trends, individual differences, and modifiers. Cereb. Cortex 15(11), 1676-1689.
164. N. Raz and K. Rodrigue (2006) Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev. 30(6), 730-748.
165. K. Reinikainen, H. Soininen and P. Riekkinen (1990) Neurotransmitter changes in Alzheimer’s disease: implications to diagnostics and therapy. J. Neurosci. Res. 27(4), 576-586.
166. G. Roman (2005) Cholinergic dysfunction in vascular dementia. Curr. Psychiatry Rep. 7 18-26.
167. D. Salat (2004) Thinning of the cerebral cortex in aging. Cereb. Cortex. 14(7), 721-730.
168. N. Salem Jr., B. Litamn, H. Kim and K. Gawrisch (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 945-959.
169. T. Salthouse (1994) The aging of working memory. Neuropsychology 8 535.
170. E. Sametsky (2010) Synaptic strength and postsynaptically silent synapses through advanced aging in rat hippocampal CA1 pyramidal neurons. Neurobiol. Aging 31(5), 813-825.
171. T. Sanders, M. Vickers and A. Haines (1981) Effects on blood lipids and haemostasis of a supplement of cod-liver oil rich in eicosapentaenoic and docosahexaenoic acids in healthy young men. Clin. Sci. 61 317-324.
172. Y. Sato and T. Endo (2010) Alteration of brain glycoproteins during aging. Geriatr. Gerontol. Int. 10(Suppl. 1), S32-S40.
173. E. Schaefer (2002) Lipoproteins, nutrition, and heart disease. Am. J. Clin. Nutr. 75 191-212.
174. E. Schaefer, V. Bongar and A. Beiser (2006) Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch. Neurol. 63(11), 1545-1550.
175. B. Schneider and M. Pichora-Fuller (2000) Implications of perceptual deterioration for cognitive aging research. F. Craik, T. Salthouse (Eds) The Handbook of Aging and Cognition second ed. Mahwah: Erlbaum 155.
176. G. Segovia, A. Porras, A. Del Arco and F. Mora (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech. Ageing Dev. 122 1-2.
177. D. Selkoe (1989) Amyloid β protein precursor and the pathogenesis of Alzheimer’s disease. Cell 58 611-612.
178. D. Selkoe (1999) Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399 A23-A31.
179. A. Simopoulos (1999) Genetic variation and nutrition. Nutr. Rev. 57 S10-S19.
180. A. Simopoulos (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 233(6), 674-688.
181. P. Singer, W. Jaeger and M. Wirth (1983) Lipid and blood pressure-lowering effect of mackerel diet in man. Atherosclerosis 49 99-108.
182. S. Sisodia and D. Price (1995) Role of the beta-amyloid protein in Alzheimer’s disease. FASEB J. 9 366-370.
183. D. Snowdon, L. Greiner, J. Mortimer, K. Riley, P. Greiner and W. Markesbery (1997) Brain infarction and the clinical expression of Alzheimer disease: the nun study. JAMA 277 813-817.
184. R. Soberman and P. Christmas (2003) The organization and consequences of eicosanoid signaling. J. Clin. Invest 111(8), 1107-1113.
185. M. Söderberg, C. Edlund, K. Kristensson and G. Dallner (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease. Lipids 26(6), 421-425.
186. C. Solsona-Sancho and J. Blasi-Cabus (1999) Neuronal membrane and aging. Electrophysiological aspects. Rev. Neurol. 29(11), 1083-1088.
187. G. Sorrentino, R. Migliaccio and V. Bonavita (2008) Treatment of vascular dementia: the route of prevention. Eur. Neurol. 60 217-223.
188. J. Staessen, T. Richart and W. Birkenhager (2007) Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 49 389-400.
189. H. Su, L. Bernardo, M. Mirmiran, X. Ma, T. Corso, P. Nathanielsz, et al. (1999) Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatr. Res. 45(1), 87-93.
190. H. Suzuki, S. Park, M. Tamura and S. Ando (1998) Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech. Ageing Dev. 101 119-128.
191. L. Svennerholm (1968) Distribution and fatty acid composition of phosphoglycerides in normal human brain. J. Lipid. Res. 9 570-579.
192. J. Sweet, Y. Such, B. Leahy, C. Abramowitz and C. Nowinski (1999) Normative clinical relationships between orientation and memory: age as an important moderator variable. Clin. Neuropsychol. 13(4), 495-508.
193. V. Taler and N. Phillips (2008) Language performance in Alzheimer’s disease and mild cognitive impairment: a comparative review. J. Clin. Exp. Neuropsychol. 30(5), 501-556.
194. Z. Tan, W. Harris, A. Beiser, R. Au, J. Himali, S. Debette, et al. (2012) Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 78 658-664.
195. P. Tiraboschi, L. Hansen, L. Thal and J. Corey-Bloom (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62(11), 1984-1989.
196. H. Tsukada, T. Kakiuchi, D. Fukumoto, S. Nishiyama and K. Koga (2000) Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain. Res. 862 180-186.
197. R. Uauy and A. Dangour (2006) Nutrition in brain development and aging: role of essential fatty acids. Nutr. Rev. 64 S24-S33.
198. L. Vallieres (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 22(2), 486-492.
199. G. Vatassery, J. Lai, W. Smith and H. Quach (1998) Aging is associated with a decrease in synaptosomal glutamate uptake and an increase in the susceptibility of synaptosomal vitamin E to oxidative stress. Neurochem. Res. 23 121-125.
200. P. Verhaeghen and J. Cerella (2002) Aging, executive control, and attention: a review of meta-analyses. Neurosci. Behav. Rev. 26 849.
201. J. Virtanen, D. Siscovick, W. Longstreth, L. Kuller Jr and D. Mozaffarian (2008) Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71 439-446.
202. A. Viswanathan and W. Rocca (2009) Vascular risk factors and dementia: how to move forward? Neurology 72 368-374.
203. A. Viswanathan and H. Chabriat (2006) Cerebral microhemorrhage. Stroke 37 550-555.
204. R. von Houwelingen, A. Nordoy, E. Van Der Beek, U. Houtsmuller, M. De Metz and G. Hornstra (1987) Effect of a moderate fish intake on blood pressure, bleeding time, hematology, and clinical chemistry in healthy males. Am. J. Clin. Nutr. 46 424-436.
205. C. von Schacky and W. Harris (2007) Cardiovascular benefits of omega-3 fatty acids. Cardiovasc. Res. 73 310-315.
206. C. von Schacky, S. Fisher and P. Weber (1985) Long-term effects of dietary marine w-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest. 76 1626-1631.
207. K. Wada, A. Nakajima, K. Katayama, C. Kudo, A. Shibuya, N. Kubota, et al. (2006) Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281 12673-12681.
208. P. Wainwright, M. Bulman Fleming, S. Levesque, L. Mustsaers and D. Mutcheon (1998) A saturated fat diet during development alters dendritic growth in mouse brain. Nutr. Neurosci. 1 49-58.
209. E. Wang and S. Snyder (1998) Handbook of the Aging Brain San Diego: Academic Press
210. Y. Wang, G. Chan, J. Holden, T. Dobko, E. Mak, M. Schulzer, et al. (1998) Age-dependent decline of dopamine d1 receptors in human brain: a PET study. Synapse 30(1), 56-61.
211. G. Wenk (2003) Neuropathologic changes in Alzheimer’s disease. J. Clin. Psychiatry 64(Suppl. 9), 7-10.
212. G. Wenk, G. Quack and H. Moebius (2000) No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sci. 66 1979-1983.
213. R. West (1996) An application of prefrontal cortex function theory to cognitive aging. Psychol. Bull. 120 272.
214. J. Whelan (2008) (n-6) and (n-3) Polyunsaturated fatty acids and the aging brain: food for thought. J. Nutr. 138(12), 2521-2522.
215. N. Whitney (2009) Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 108(6), 1343-1359.
216. Who.int (2013) WHO | Ageing and Life-Course. [online] Available at: (accessed 27.05.13).
217. Who.int (2012) WHO | Dementia. [online] Available at: (accessed 27.05.13).
218. C. Williams and G. Burdge (2006) Long-chain n-3 PUFA: plant v marine sources. Proc. Nutr. Soc. 65 42-50.
219. D. Wong (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226(4681), 1393-1396.
220. M. Yamamoto, T. Suhara, T. Okubo, T. Ichimiya, Y. Sudo, Y. Inoue, et al. (2002) Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci. 71 751-757.
221. B. Yankner, L. Duffy and D. Kirschner (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science 250(4978), 279-282.
222. C. Yoon, J. Shin, H. Kim, H. Cho, Y. Noh, G. Kim, et al. (2013) Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease: PiB-PET-based study. Neurology 80(6), 569-573.
223. K. Yurko-Mauro, D. McCarthy and D. Rom (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer’s Dement. 6 456-464.
224. R. Zec (1993) Neuropsychological functioning in Alzheimer’s disease. R. Parks, R. Zec, R. Wilson (Eds) Neuropsychology of Alzheimer’s Disease and Other Dementias first ed. New York: Oxford University Press 3-80.
225. T. Zigova, V. Pencea, S. Wiegand and M. Luskin (1998) Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Cell Neurosci. 11(4), 234-245.
226. F. Bermejo-Pareja, J. Benito-León, S. Vega, M. Medrano and G. Román (2008) Incidence and subtypes of dementia in three elderly populations of central Spain. J. Neurol. Sci. 264(1–2), 63-72.
227. R. Brookmeyer, E. Johnson, K. Ziegler-Graham and H. Arrighi (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3(3), 186-191.
228. A. Dicarlo (2002) Incidence of dementia, Alzheimer’s disease, and vascular dementia in Italy. The ILSA Study. J. Am. Geriatr. Soc. 50(1), 41-48.
229. P. Doraswamy, D. Steffens, S. Pitchumoni and S. Tabrizi (1998) Early recognition of Alzheimer’s disease: what is consensual? What is controversial? What is practical? J. Clin. Psychiatry 59(Suppl. 13), 6-18.
230. S. Gauthier (1999) Managing expectations in the long-term treatment of Alzheimer’s Disease. Gerontology 45(Suppl. 1), 33-38.
231. A. Wimo, L. Jonsson and B. Winblad (2006) An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn. Disor. 21(3), 175-181.